Ben-Jonathan N , Mershon JL , Allen DL , Steinmetz RM . Extra pituitary prolactin: Distribution, regulation, functions, and clinical aspects . Endocrin Rev1996; 17: 639–669 .
2.
Berczi I . The role of prolactin in the pathogenesis of autoimmune disease . Endocr Pathol1993; 4: 178–195 .
3.
Lavalle C et al. Prolactin and gonadal hormones: A key relationship that may have clinical, monitoring and therapeutic implications in systemic lupus erythematosus . Lupus1993; 2: 71–75 .
4.
Berczi I . Prolactin, pregnancy and autoimmune disease . J Rheumatol1993; 20: 1095–1100 .
5.
Draca S . Prolactin as an immunoreactive agent . Immunol Cell Biol1995; 73: 481–483 .
6.
Walker SE , Allen SH , Hoffman RW , McMurray RW . Review. Prolactin: a stimulator of disease activity in systemic lupus erythematosus . Lupus1995; 4: 3–9 .
7.
Matera L . Endocrine, paracrine and autocrine actions of prolactin on immune cells . Life Sci1996; 59: 599–614 .
8.
Berczi I , Chalmers IM , Nagy E , Warrington RJ . The immune effects of neuropeptides . Balliere 's Clin Rheumatol1996; 10: 227–257 .
9.
McMurray RW . Prolactin and systemic lupus erythematosus . Ann Med Interne1996; 147: 253–258 .
10.
Li-Yuan Y . Molecular actions of prolactin in the immune system . PSEBM1997; 215: 35–52 .
11.
Berczi I . Pituitary hormones and immune function . Acta Paediatr Suppl1997; 423: 70–75 .
12.
Walker SE et al. Effects of prolactin in stimulating disease activity in systemic lupus erythematosus . Proc N Y Acad Sci1998; 840: 762–772 .
13.
Hartmann DP , Holaday JW , Bernton EW . Inhibition of lymphocyte proliferation by antibodies to prolactin . FASEB J1989; 3: 2194–2202 .
14.
Viselli SM et al. Prolactin-induced mitogenesis of lymphocytes from ovariectomized rats . Endocrinology1991; 129: 983–990 .
15.
Russell DH et al. Prolactin receptors on human T and B Lymphocytes: Antagonism of prolactin binding by cyclosporine . J Immunol1985; 134: 3027–3031 .
16.
Thoreau E et al. Structural symmetry of the extracellular domain of the cytokine/growth hormone/prolactin receptor family and interferon receptors revealed by hydrophobic cluster analysis . FEBS Lett1991; 282: 26–31 .
17.
Nagy E , Berczi I . Immunodeficiency in hypophysectomized rats . Acta Endocrinol1978; 89: 530–537 .
18.
Dardenne M et al. Neuroendocrine control of thymic hormonal production. I. Prolactin stimulates in vivo and in vitro the production of thymulin by human and murine thymic epithelial cells . Endocrinology1989; 125: 3–12 .
19.
de Mello-Coelho V , Villa-Verde DMS , Dardenne M , Savino W . Pituitary hormones modulate cell-cell interactions between thymocytes and thymic epithelial cells . J Neuroimmunol1997; 76: 39–49 .
20.
Gaufo GO , Diamond MC . Prolactin increases CD4=CD8 cell ratio in thymus-grafted congenitally athymic nude mice . Proc Natl Acad Sci USA1996; 93: 4165–4169 .
21.
Bryant HU , Holaday JW , Bernton EW . Cysteamine produces dose-related bidirectional immunomodulatory effects in mice . J Pharm Exp Therap1989; 249: 424–429 .
22.
Cross RJ , Campbell JL , Roszman TL . Potentiation of antibody responsiveness after the transplantation of a syngeneic pituitary gland . J Neuroimmunol1989; 25: 29–35 .
23.
Kawai M , Kishi K . In vitro studies of the sitmulation of insulin secretion and B-cell proliferaiton by rat placental lactogen-II during pregnancy in rats . J Reprod Fertil1997; 109: 145–152 .
24.
Zimmer JP et al. Relationship between serum prolactin, lactation and changes in maternal blood B-cell (CD19) percents during the first 8 months post-partum . J Reprod Immuol1996; 30: 81–95 .
25.
Bernton EW , Meltzer MS , Holaday JW . Suppression of macrophage activation and T-lymphocyte function in hypoprolactinemic mice . Science1988; 239: 401–404 .
26.
Kumar A , Singh SM , Sodhi A . Effect of prolactin on nitric oxide and interleukin-1 production of murine peritoneal macrophages: Role of Ca2 and protein kinase C . Int J Immunopharmac1997; 19: 129–133 .
27.
Ortega E , Forner MA , Barriga C . Effect of prolactin on the in vitro phagocytic capacity of macrophages . Comp Immun Microbiol Infect Dis1996; 19: 139–146 .
28.
Cesario TC et al. Enhanced yields of gamma interferon in pro lactin-treated human peripheral blood mononuclear cells. 1994; 205: 89–95 .
29.
Gaytan F et al. Role of prolactin in the regulation of macrophages and in the proliferative activity of vascular cells in newly formed and regressing rat corpora lutea . Biol Reprod1997; 57: 478–486 .
30.
Matera L et al. Role of prolactin in the in vitro development of interleukin-2-driven anti-tumoral lymphokine-activated killer cells . Immunology1996; 89: 619–626 .
31.
Risking PN et al. The role of prolactin in autoimmune demyelination: Suppression of experimental allergic encephalomyelitis by bromocrip-tine . Ann Neurol1991; 29: 542–547 .
32.
Berczi I , Nagy E , Asa SL , Kovacs K . The influence of pituitary hormones in adjuvant arthritis . Arthritis Rheum1984; 27: 682–688 .
33.
Hedner LP , Bynke G . Endogenous iridocyclitis relieved during treatment with bromocriptine . Am J Ophthalmol1985; 100: 618-619 .
34.
Lever EG , McKerron CG . Auto-immune Addison's disease associated with hyperprolactinaemia . Clin Endocrinol1984; 21: 451–457 .
35.
Ferrari C et al. Thyroid autoimmunity in hyperprolactinemic disorders . Acta Endocrinol1983; 104: 35–41 .
36.
Honegger J et al. Lymphocytic and granulomatous hypophysitis: Experience with nine cases . Neurosurgery. 1997; 40: 713–723 .
37.
Toubi E , Gabriel D , Golan TD . High association between hyperprolactinemia and anticardiolipin antibodies . J Rheumatol1997; 24: 1451-1451 (letter).
38.
Buskila D et al. Autoantibody profile in the sera of women with hyperprolactinemia . J Autoimmunity1995; 8: 415–424 .
39.
Krause I et al. Anti-endothelial cell antibodies in the sera of hyperprolactinemic women . Lupus1998; 7: 377–382 .
40.
Kawai T , Katoh K , Tani K . Hyperprolactinemia preceding development of autoimmune disease . J Rheumatol1996; 23: 1483–1484 (letter).
41.
Gutierrez MA et al. Hyperprolactinaemia in primary Sjogren ' s syndrome . Ann Rheum Dis1994; 53: 425–428 (letter).
42.
Kucharz EJ et al. High serum level of prolactin in patients with systemic sclerosis . Clin Rheumatol1996; 15: 314-314 .
43.
McMurray RW et al. Elevated serum prolactin levels in children with juvenile rheumatoid arthritis and antinuclear antibody seropositivity . J Rheumatol1995; 22: 1577–1580 .
44.
Picco P et al. Prolactin and inteleukin 6 in prepubertal girls with juvenile chronic arthritis . J Rheumatol1998; 25: 347–351 .
45.
Lavalle C et al. Correlation study between prolactin and androgens in male patients with systemic lupus eythematosus . J Rheumatol1987; 14: 268–272 .
46.
Jara LJ et al. Hyperprolactinemia in systemic lupus erythematosus: Association with disease activity . Am J Med Sci1992; 303: 222–226 .
47.
Jara-Quezada L , Graef A , Lavalle C . Prolactin and gonadal hormones during pregnancy in systemic lupus erythematosus . J Rheumatol1991; 18: 349–353 .
48.
Pauzner R , Urowitz MB , Gladman DD , Gough JM . Prolactin in systemic lupus eythematosus . J Rheumatol1994; 21: 2064–2067 .
49.
Buskila D et al. No correlation between prolactin levels and clinical activity in patients with systemic lupus erythematosus . J Rheumatol1996; 23: 629–632 .
50.
Allen SH et al. Prolactin levels and antinuclear antibody profiles in women tested for connective tissue disease . Lupus1996; 5: 30–37 .
51.
Neidhart M . Elevated serum prolactin or elevated prolactin/cortisol ratio are associated with autoimmune processes in systemic lupus erythematosus and other connective tissue diseases . J Rheumatol1996; 23: 476–481 .
52.
Munoz JA et al. Sex hormones in chronic systemic lupus erythematosus. Correlation with clinical and biological parameters . Ann de Med Intern1994; 145: 459–463 .
53.
Ostendorf B et al. Hyperprolactinemia in systemic lupus erythematosus . Scand J Rheumatol1996; 25: 97–102 .
54.
Jimena P et al. Prolactin levels in patients with systemic lupus erythematosus: a case controlled study . Lupus1998; 7: 383–386 .
55.
El-Garf A et al. Prolactin hormone in juvenile systemic lupus erythematosus: A possible relationship to disease activity and CNS manifestations . J Rheumatol1996; 23: 374–377 .
56.
Miranda JM et al. Clinical significance of serum and urine prolactin levels in lupus glomerulonephritis . Lupus1998; 7: 387–391 .
57.
McMurray et al. Longstanding hyperprolactinemia associated with systemic lupus erythematosus: Possible hormonal stimulation of an autoimmune disease . J Rheumatol1994. 21: 843–850 .
58.
Gutierrez, MA et al. Prolactin and systemic lupus erythematosus: Prolactin secretion by SLE lymphocytes and proliferative (autocrine) activity . Lupus1995; 4: 348–352 .
59.
Ferreira C et al. Plasma homovanillic acid and prolactin in systemic lupus erythematosus . Lupus1998; 7: 392–397 .
60.
Leaños A , Pascoe D , Fraga A , Blanco F . Anti-prolactin autoantibodies in systemic lupus erythematosus patients with associated hyperprolactinemia . Lupus1998; 7: 398–405 .
61.
Gutierrez MA et al. Hypothalamic-pituitary-adrenal axis function and prolactin secretion in systemic lupus erythematosus . Lupus1998; 7: 404–408 .
62.
Rovensky J et al. The hypothalamic-pituitary response in SLE. Regulation of prolactin, growth hormone and cortisol release . Lupus1998; 7: 409–413 .
63.
McMurray RW , Weidensaul D , Allen SH , Walker SE . Efficacy of bromocriptine in an open label therapeutic trial for systemic lupus erythematosus . J Rheumatol1995; 22: 2084–2091 .
64.
Alvarez-Nemegyei J et al. Bromocriptine in systemic lupus erythematosus: A double-blind, randomized, placebo-controlled study . Lupus1998; 7: 414–419 .
65.
Hahn BH . Animal models of systemic lupus erythematosus. In Wallace DJ , Hahn BH (eds) Dubois' Lupus Erythematosus, Fifth edition. Baltimore: Williams & Wilkins , 1997, 339–380.
66.
McMurray R , Keisler D , Kanuckel K , Izui S , Walker SE . Prolactin influences autoimmune disease activity in the female B/W mouse . J Immunol1991; 147: 3780–3787 .
67.
Walker SE , Allen SH , McMurray RW . Prolactin and autoimmune disease . Trends Endocrinol and Metabol1993; 4: 147–151 .
68.
McMurray RW , Keisler D , Izui W , Walker SE . Effects of parturition, suckling and pseudopregnancy on variables of disease activity in the B/W mouse model of systemic lupus erythematosus . J Rheumatol1993; 20: 1143–1151 .
69.
McMurray RW , Keisler D , Izui S , Walker SE . Hyperprolactinemia in male NZB/NZW (B/W) F1 mice; Accelerated autoimmune disease with normal circulating testosterone . Clin Immunol Immunopathol1994; 71: 338–343 .
70.
Elbourne KB , Keisler D , McMurray RW . Differential effects of estrogen and prolactin on autoimmune disease in the NZB/NZW F1 mouse model of systemic lupus erythematosus . Lupus1998; 7: 420–427 .
